About this event

  • Date and time Thu 2 Dec 2021 from 6:00pm to 8:00pm
  • Location Online
  • Organised by Respiratory Medicine

This is a free event

Join this webinar that highlights the latest advances in the diagnosis and management of Interstitial Lung Disease (ILD).

Talks will be given by world experts in ILD and will be tailored to an audience of general respiratory physicians. The webinar will finish with an interactive panel discussion that will cover future directions in ILD.

Aims for this event include:

  • To highlight the importance of genetics in the early diagnosis of Idiopathic Pulmonary Fibrosis (IPF)
  • To demonstrate the potential for biomarkers to stratify IPF to different targeted therapies
  • To highlight the latest advances in the management of connective tissue disease-related ILD

CPD learning accredited.

This webinar is available for on-demand viewing. The webinar recording will be available for registered delegates up to 30 days after the live webinar broadcast via Zoom. The link will be sent 24 hours after the webinar takes place. 

Join in the conversation online by using #RSMLive 
Follow us on Twitter: @RoySocMed


Standard pricing available until 02 December 2021.


RSM Fellow RSM Associate RSM Retired Fellow RSM Trainee RSM Student
£0.00 £0.00 £0.00 £0.00 £0.00

Non - Member

Consultant / GP AHP / Nurse / Midwife Non Healthcare Professional Trainee Student
£0.00 £0.00 £0.00 £0.00 £0.00

Key speakers

Louise Wain

Professor Louise Wain

Genetic Epidemiologist at the University of Leicester; Chair of Respiratory Research at the British Lung Foundation

Speaker's biography

Louise Wain was appointed in 2017 as a GSK/British Lung Foundation Chair of Respiratory Research and is a member of the Genetic Epidemiology group at the University of Leicester. She has research interests in the genetic architecture of respiratory health and disease, focusing on pulmonary fibrosis and chronic obstructive pulmonary disease. Her areas of expertise include the analysis of single nucleotide polymorphisms and copy number variation (CNV) using array data and re-sequencing approaches. Louise has played a key role in large consortium projects including SpiroMeta (lung function), the International Consortium for Blood Pressure (ICBP) GWAS and has led the largest GWAS of IPF susceptibility to date. Louise was a co-lead of the UK BiLEVE study – the first genetic study in UK Biobank – and is an active researcher working on pulmonary fibrosis in the Genomics England 100,000 Genomes Project. Louise is an Associate Editor for the European Respiratory Journal and, in addition to teaching at undergraduate and Masters level, leads doctoral training programme activities at the University of Leicester. She is currently one of the lead investigators of the new Post-Hospitalisation COVID19 (PHOSP-COVID) Study and co-investigator of the largest UK study of post-COVID ILD.

Dr Puja Mehta

Dr Puja Mehta

Clinical Research Training Fellow at University College London 

Speaker's biography

Puja Mehta is a senior specialist registrar in Rheumatology in the London Deanery and is undertaking basic research in post-COVID interstitial lung disease (ILD) at UCL Respiratory.

Her research interests include rheumatic-associated ILD and experimental therapeutics.
During a pharmaceutical industry fellowship, Puja designed an interventional clinical trial of a monoclonal antibody in rheumatoid arthritis and an observational study to delineate the natural history of rheumatoid-arthritis-associated ILD (RA-ILD) to contextualise potential pulmonary safety signals.

Puja regularly teaches medical students and MSc students at UCL and Imperial College London.

Professor Gisli Jenkins

Chair of Thoracic Medicine at the National Heart & Lung Institute


View programme

Welcome and introduciton

Dr Sachin Ananth, Foundation Year 2 Doctor, West Hertfordshire NHS Trust

Genetics in the Early Diagnosis of Idiopathic Pulmonary Fibrosis (IPF)

Professor Louise Wain, Genetic Epidemiologist at the University of Leicester; Chair of Respiratory Research at the British Lung Foundation

Personalised Medicine in Interstitial Lung Disease (ILD)

Professor Gisli Jenkins, Chair of Thoracic Medicine at the National Heart & Lung Institute

Management of Rheumatoid-arthritis associated Interstitial Lung Disease (ILD)

Dr Puja Mehta, Clinical Research Training Fellow at University College London

Panel discussion



Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM.

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted. 

Special rates for difficult times
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s ​weekly COVID-19 Series ​webinars remain free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.

Man searching computer

Join the RSM and get unlimited digital learning and e-resources access

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy unlimited digital learning any time you need and access to e-journals, e-books and 6 huge medical databases to support your clinical decision-making and research.

Our e-resources are updated continuously to ensure you receive the cutting edge knowledge you need. 


Become a member